Terms: = Skin cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Prognosis
2067 results:
1. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
Hong S; Lee JH; Heo JY; Suh KJ; Kim SH; Kim YJ; Kim JH
J Cancer Res Clin Oncol; 2024 Apr; 150(4):186. PubMed ID: 38600328
[TBL] [Abstract] [Full Text] [Related]
2. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
[TBL] [Abstract] [Full Text] [Related]
3. Malignancy After Living Donor Liver Transplantation.
Kobayashi T; Miura K; Ishikawa H; Sakata J; Takizawa K; Hirose Y; Toge K; Saito S; Abe S; Kawachi Y; Ichikawa H; Shimada Y; Takahashi Y; Wakai T; Kinoshita Y
Transplant Proc; 2024 Apr; 56(3):660-666. PubMed ID: 38519268
[TBL] [Abstract] [Full Text] [Related]
4. Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting.
Khan F; Hashmi F; Ghahramanyan N; Baloyan E; Tamamyan G; Konopleva M; Pemmaraju N; Voskanyan A
Oncology (Williston Park); 2024 Mar; 38(3):104-106. PubMed ID: 38517410
[TBL] [Abstract] [Full Text] [Related]
5. Effects of COVID-19 Pandemic on the Diagnosis of Melanoma and Keratinocyte Carcinomas: a Systematic Review and Meta-analysis.
Díaz-Calvillo P; Muñoz-Barba D; Ureña-Paniego C; Maul LV; Cerminara S; Kostner L; Martínez López A; Arias-Santiago S
Acta Derm Venereol; 2024 Mar; 104():adv19460. PubMed ID: 38483083
[TBL] [Abstract] [Full Text] [Related]
6. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
7. Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma.
Tan SX; Chong S; Rowe C; Galbraith J; Dight J; Zhou C; Malt M; Smithers BM; Khosrotehrani K
Exp Dermatol; 2024 Mar; 33(3):e15041. PubMed ID: 38433382
[TBL] [Abstract] [Full Text] [Related]
8. Superficial dedifferentiated liposarcoma: A clinicopathologic study.
Bourgeau M; Gandhi JS; Deeb KK; Bahrami A
Hum Pathol; 2024 Mar; 145():63-70. PubMed ID: 38423223
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of Social Vulnerabilities of Care and prognosis in Adult Ocular Melanomas in the US.
Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
[TBL] [Abstract] [Full Text] [Related]
10. Nivolumab Rechallenge After Immune-related Adverse Events in Patients With Unresectable Advanced or Recurrent Esophageal cancer.
Ueno K; Suzuki K; Saito K; Shinohara H; Miura A
In Vivo; 2024; 38(2):794-799. PubMed ID: 38418136
[TBL] [Abstract] [Full Text] [Related]
11. On-Site Melanoma Diagnosis Utilizing a Swellable Microneedle-Assisted skin Interstitial Fluid Sampling and a Microfluidic Particle Dam for Visual Quantification of S100A1.
Wang G; Zhang Y; Kwong HK; Zheng M; Wu J; Cui C; Chan KWY; Xu C; Chen TH
Adv Sci (Weinh); 2024 Apr; 11(16):e2306188. PubMed ID: 38417122
[TBL] [Abstract] [Full Text] [Related]
12. Risk of progression of early-stage mycosis fungoides, 10-year experience.
Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
[TBL] [Abstract] [Full Text] [Related]
13. A rare synchronous presentation of primary malignant melanoma in cervix and vagina.
Pai UKN; Pillai S; Arunkumar NR
J Cancer Res Ther; 2023 Oct; 19(7):2108-2110. PubMed ID: 38376333
[TBL] [Abstract] [Full Text] [Related]
14. Recent treatment and prognosis in 643 patients with extramammary Paget's disease.
Hatta N; Ogata D; Asai J; Maekawa T; Ito T; Takenouchi T; Kiniwa Y; Miyashita A; Miyagawa T; Muto I; Yamamoto Y; Nagano T; Kiyohara Y; Nakano E; Ohe S; Yamaguchi B; Fukuyama M; Matsuya T; Tsutsumida A; Namikawa K; Yamazaki N
Exp Dermatol; 2024 Feb; 33(2):e15030. PubMed ID: 38375900
[TBL] [Abstract] [Full Text] [Related]
15. Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB.
Amaral T; Nanz L; Stadler R; Berking C; Ulmer A; Forschner A; Meiwes A; Wolfsperger F; Meraz-Torres F; Chatziioannou E; Martus P; Flatz L; Garbe C; Leiter U
Eur J Cancer; 2024 Apr; 201():113912. PubMed ID: 38368742
[TBL] [Abstract] [Full Text] [Related]
16. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.
de Bruyn DP; van Poppelen NM; Brands T; van den Boom SC; Eikenboom E; Wagner A; van Veghel-Plandsoen MM; Geeven G; Beverloo B; van Rij CM; Verdijk RM; Naus NC; Bagger MM; Kiilgaard JF; de Klein A; Brosens E; Kiliç E
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):11. PubMed ID: 38319670
[TBL] [Abstract] [Full Text] [Related]
18. Intraventricular Cerebral Metastases: A Comprehensive Systematic Review.
Scalia G; Silven MP; Costanzo R; Porzio M; Maugeri R; Iacopino DG; Nicoletti GF; Umana GE
Anticancer Res; 2024 Feb; 44(2):453-462. PubMed ID: 38307552
[TBL] [Abstract] [Full Text] [Related]
19. Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
Zakria D; Brownstone N; Berman B; Ceilley R; Cronin TA; Del Rosso JQ; Ferris LK; Goldenberg G; Siegel D
J Drugs Dermatol; 2024 Feb; 23(2):54-60. PubMed ID: 38306124
[TBL] [Abstract] [Full Text] [Related]
20. A prediction model for response to immune checkpoint inhibition in advanced melanoma.
van Duin IAJ; Verheijden RJ; van Diest PJ; Blokx WAM; El-Sharouni MA; Verhoeff JJC; Leiner T; van den Eertwegh AJM; de Groot JWB; van Not OJ; Aarts MJB; van den Berkmortel FWPJ; Blank CU; Haanen JBAG; Hospers GAP; Piersma D; van Rijn RS; van der Veldt AAM; Vreugdenhil G; Wouters MWJM; Stevense-den Boer MAM; Boers-Sonderen MJ; Kapiteijn E; Suijkerbuijk KPM; Elias SG
Int J Cancer; 2024 May; 154(10):1760-1771. PubMed ID: 38296842
[TBL] [Abstract] [Full Text] [Related]
[Next]
